{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T02:56:17Z","timestamp":1789181777702,"version":"build-2803163510"},"reference-count":79,"publisher":"Informa UK Limited","issue":"2","content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Pharmacogenomics"],"published-print":{"date-parts":[[2023,1]]},"DOI":"10.2217\/pgs-2022-0135","type":"journal-article","created":{"date-parts":[[2023,1,13]],"date-time":"2023-01-13T10:52:47Z","timestamp":1673607167000},"page":"93-106","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":12,"title":["<i>DPYD<\/i>\n            Genotyping and Predicting Fluoropyrimidine Toxicity: Where do we Stand?"],"prefix":"10.1080","volume":"24","author":[{"given":"Lucija","family":"Le\u0161njakovi\u0107","sequence":"first","affiliation":[{"name":"Faculty of Pharmacy and Biochemistry, University of Zagreb, Zagreb, Croatia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3898-4554","authenticated-orcid":false,"given":"Lana","family":"Ganoci","sequence":"additional","affiliation":[{"name":"Division of Pharmacogenomics and Therapy Individualization, Department of Laboratory Diagnostics, University Hospital Centre Zagreb, Zagreb, Croatia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ivan","family":"Bili\u0107","sequence":"additional","affiliation":[{"name":"Department of Oncology, University Hospital Centre Zagreb, Zagreb, Croatia"},{"name":"School of Medicine, University of Zagreb, Zagreb, Croatia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2491-1920","authenticated-orcid":false,"given":"Livija","family":"\u0160imi\u010devi\u0107","sequence":"additional","affiliation":[{"name":"Division of Pharmacogenomics and Therapy Individualization, Department of Laboratory Diagnostics, University Hospital Centre Zagreb, Zagreb, Croatia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5566-9356","authenticated-orcid":false,"given":"Iva","family":"Mucalo","sequence":"additional","affiliation":[{"name":"Centre for Applied Pharmacy, Faculty of Pharmacy and Biochemistry, University of Zagreb, Zagreb, Croatia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stjepko","family":"Ple\u0161tina","sequence":"additional","affiliation":[{"name":"Department of Oncology, University Hospital Centre Zagreb, Zagreb, Croatia"},{"name":"School of Medicine, University of Zagreb, Zagreb, Croatia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6016-1699","authenticated-orcid":false,"given":"Nada","family":"Bo\u017eina","sequence":"additional","affiliation":[{"name":"Department of Pharmacology, School of Medicine, University of Zagreb, Zagreb, Croatia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2023,1,13]]},"reference":[{"key":"e_1_3_3_2_1","doi-asserted-by":"publisher","DOI":"10.1002\/cpt.911"},{"key":"e_1_3_3_3_1","doi-asserted-by":"publisher","DOI":"10.1097\/FPC.0b013e32833c6107"},{"key":"e_1_3_3_4_1","unstructured":"WHO . Model List of Essential Medicines\u201322nd List 2021 (2021). https:\/\/list.essentialmeds.org\/"},{"key":"e_1_3_3_5_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41431-019-0540-0"},{"key":"e_1_3_3_6_1","doi-asserted-by":"publisher","DOI":"10.1002\/cpt.2667"},{"key":"e_1_3_3_7_1","unstructured":"EMA . Referral under Article 31 of Directive 2001\/83\/EC resulting from pharmacovigilance data: fluorouracil and fluorouracil-related substances (capecitabine tegafur and flucytosine) containing medicinal products (2020). https:\/\/www.ema.europa.eu\/en\/documents\/referral\/fluorouracil-fluorouracil-related-substances-article-31-referral-assessment-report_en.pdf"},{"key":"e_1_3_3_8_1","doi-asserted-by":"publisher","DOI":"10.5306\/wjco.v11.i12.1008"},{"key":"e_1_3_3_9_1","doi-asserted-by":"publisher","DOI":"10.1002\/onco.13967"},{"key":"e_1_3_3_10_1","unstructured":"Summary of product characteristics: Xeloda 150mg film-coated tablets (2021). https:\/\/www.ema.europa.eu\/en\/documents\/product-information\/xeloda-epar-product-information_en.pdf (Accessed 15July2022)."},{"key":"e_1_3_3_11_1","unstructured":"Summary of product characteristics: fluorouracil 25mg\/ml injection (2022). www.medicines.org.uk\/emc\/product\/3790\/smpc#UNDESIRABLE_EFFECTS (Accessed 15July2022)."},{"key":"e_1_3_3_12_1","unstructured":"Summary of product characteristics: Teysuno 15mg\/4.35mg\/11.8mg hard capsules (2022). https:\/\/www.ema.europa.eu\/en\/documents\/product-information\/teysuno-epar-product-information_en.pdf (Accesed 15 July 2022)."},{"key":"e_1_3_3_13_1","doi-asserted-by":"publisher","DOI":"10.1111\/bcpt.13782"},{"key":"e_1_3_3_14_1","doi-asserted-by":"publisher","DOI":"10.1080\/15257770.2014.894197"},{"key":"e_1_3_3_15_1","unstructured":"Genome Aggregation Database (gnomAD) . DPYD-dihydropyrimidine dehydrogenase (2022). https:\/\/gnomad.broadinstitute.org\/gene\/ENSG00000188641?dataset=gnomad_r2_1"},{"key":"e_1_3_3_16_1","doi-asserted-by":"publisher","DOI":"10.4414\/smw.2020.20375"},{"key":"e_1_3_3_17_1","doi-asserted-by":"publisher","DOI":"10.1172\/JCI118830"},{"key":"e_1_3_3_18_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00280-006-0392-5"},{"key":"e_1_3_3_19_1","doi-asserted-by":"publisher","DOI":"10.1042\/bj3640157"},{"key":"e_1_3_3_20_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00439-010-0879-3"},{"key":"e_1_3_3_21_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(18)30686-7"},{"key":"e_1_3_3_22_1","doi-asserted-by":"publisher","DOI":"10.1002\/cpt.685"},{"key":"e_1_3_3_23_1","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.32022"},{"key":"e_1_3_3_24_1","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.29025"},{"key":"e_1_3_3_25_1","doi-asserted-by":"publisher","DOI":"10.1038\/clpt.2013.69"},{"key":"e_1_3_3_26_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.annonc.2020.06.022"},{"key":"e_1_3_3_27_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.annonc.2022.07.004"},{"key":"e_1_3_3_28_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.annonc.2021.09.019"},{"key":"e_1_3_3_29_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.annonc.2020.07.011"},{"key":"e_1_3_3_30_1","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdw235"},{"key":"e_1_3_3_31_1","unstructured":"FDA . Table of Pharmacogenetic Associations (2022). https:\/\/www.fda.gov\/medical-devices\/precision-medicine\/table-pharmacogenetic-associations"},{"key":"e_1_3_3_32_1","unstructured":"FDA . Table of Pharmacogenomic Biomarkers in Drug Labeling (2022). https:\/\/www.fda.gov\/drugs\/science-and-research-drugs\/table-pharmacogenomic-biomarkers-drug-labeling"},{"key":"e_1_3_3_33_1","unstructured":"National Comprehensive Cancer Network . Colon Cancer (2022). www.nccn.org\/guidelines\/guidelines-detail"},{"key":"e_1_3_3_34_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2006.08.2644"},{"key":"e_1_3_3_35_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.22.01063"},{"key":"e_1_3_3_36_1","doi-asserted-by":"publisher","DOI":"10.1200\/OP.20.00553"},{"key":"e_1_3_3_37_1","doi-asserted-by":"publisher","DOI":"10.1038\/tpj.2015.56"},{"key":"e_1_3_3_38_1","doi-asserted-by":"publisher","DOI":"10.21037\/jgo.2018.02.03"},{"key":"e_1_3_3_39_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00280-015-2698-7"},{"key":"e_1_3_3_40_1","doi-asserted-by":"publisher","DOI":"10.4149\/neo_2009_04_303"},{"key":"e_1_3_3_41_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2018.07.009"},{"key":"e_1_3_3_42_1","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-12-3858"},{"key":"e_1_3_3_43_1","doi-asserted-by":"publisher","DOI":"10.1111\/bcp.14742"},{"key":"e_1_3_3_44_1","doi-asserted-by":"publisher","DOI":"10.1111\/bcp.15144"},{"key":"e_1_3_3_45_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0004003"},{"key":"e_1_3_3_46_1","doi-asserted-by":"publisher","DOI":"10.2217\/pgs.09.28"},{"key":"e_1_3_3_47_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00280-022-04491-7"},{"key":"e_1_3_3_48_1","doi-asserted-by":"publisher","DOI":"10.2147\/PGPM.S337147"},{"issue":"12","key":"e_1_3_3_49_1","first-page":"4705","article-title":"Clinical implications of dihydropyrimidine dehydrogenase (DPD) deficiency in patients with severe 5-fluorouracil-associated toxicity: identification of new mutations in the DPD gene","volume":"6","author":"van Kuilenburg AB","year":"2000","unstructured":"van Kuilenburg AB , HaasjesJ , RichelDJet al. Clinical implications of dihydropyrimidine dehydrogenase (DPD) deficiency in patients with severe 5-fluorouracil-associated toxicity: identification of new mutations in the DPD gene. Clin. Cancer Res.6(12), 4705\u20134712 (2000).","journal-title":"Clin. Cancer Res."},{"key":"e_1_3_3_50_1","doi-asserted-by":"publisher","DOI":"10.1038\/bjc.2017.289"},{"key":"e_1_3_3_51_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41397-019-0077-1"},{"key":"e_1_3_3_52_1","doi-asserted-by":"publisher","DOI":"10.1111\/bcp.12631"},{"key":"e_1_3_3_53_1","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-10-2209"},{"key":"e_1_3_3_54_1","doi-asserted-by":"publisher","DOI":"10.3390\/jpm11080792"},{"key":"e_1_3_3_55_1","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-13-2482"},{"key":"e_1_3_3_56_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamaoncol.2015.5392"},{"key":"e_1_3_3_57_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0175998"},{"key":"e_1_3_3_58_1","doi-asserted-by":"publisher","DOI":"10.1038\/bjc.2013.262"},{"key":"e_1_3_3_59_1","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-04-1784"},{"key":"e_1_3_3_60_1","doi-asserted-by":"publisher","DOI":"10.1038\/bjc.2013.262"},{"issue":"6","key":"e_1_3_3_61_1","first-page":"559","article-title":"Multiple organ failure due to 5-fluorouracil chemotherapy in a patient with a rare dihydropyrimidine dehydrogenase gene variant","volume":"27","author":"Lazar A","year":"2004","unstructured":"Lazar A , Mau-HolzmannUA , KolbH , ReichenmillerHE , RiessO , Sch\u00f6migE. Multiple organ failure due to 5-fluorouracil chemotherapy in a patient with a rare dihydropyrimidine dehydrogenase gene variant. Onkologie27(6), 559\u2013562 (2004).","journal-title":"Onkologie"},{"key":"e_1_3_3_62_1","doi-asserted-by":"publisher","DOI":"10.3390\/clinpract11030062"},{"key":"e_1_3_3_63_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2125.1998.00751.x"},{"key":"e_1_3_3_64_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2006.10.4182"},{"key":"e_1_3_3_65_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2013.51.1857"},{"key":"e_1_3_3_66_1","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.29654"},{"key":"e_1_3_3_67_1","doi-asserted-by":"publisher","DOI":"10.1002\/cpt.1020"},{"key":"e_1_3_3_68_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2022.113644"},{"key":"e_1_3_3_69_1","article-title":"Severe capecitabine toxicity associated with a rare DPYD variant identified through whole-genome sequencing","volume":"4","author":"Ly RC","year":"2020","unstructured":"Ly RC , SchmidtRE , KielPJet al. Severe capecitabine toxicity associated with a rare DPYD variant identified through whole-genome sequencing. JCO Precis. Oncol.4, PO.20.00067 (2020).","journal-title":"JCO Precis. Oncol."},{"key":"e_1_3_3_70_1","doi-asserted-by":"publisher","DOI":"10.3390\/ijms232213923"},{"key":"e_1_3_3_71_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.clcc.2022.05.001"},{"key":"e_1_3_3_72_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2015.63.1325"},{"key":"e_1_3_3_73_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajhg.2019.04.017"},{"key":"e_1_3_3_74_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2018.11.010"},{"key":"e_1_3_3_75_1","doi-asserted-by":"publisher","DOI":"10.1177\/1559325818803042"},{"issue":"14","key":"e_1_3_3_76_1","first-page":"1","article-title":"DPYD genotyping in patients who have planned cancer treatment with fluoropyrimidines: a health technology assessment","volume":"21","author":"Ontario Health (Quality)","year":"2021","unstructured":"Ontario Health (Quality) . DPYD genotyping in patients who have planned cancer treatment with fluoropyrimidines: a health technology assessment. Ont. Health Technol. Assess. Ser.21(14), 1\u2013186 (2021).","journal-title":"Ont. Health Technol. Assess. Ser."},{"key":"e_1_3_3_77_1","doi-asserted-by":"publisher","DOI":"10.1002\/cpt.1257"},{"key":"e_1_3_3_78_1","doi-asserted-by":"publisher","DOI":"10.1177\/1559325820951367"},{"key":"e_1_3_3_79_1","doi-asserted-by":"publisher","DOI":"10.1080\/21678707.2019.1591273"},{"key":"e_1_3_3_80_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00280-016-3063-1"}],"container-title":["Pharmacogenomics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.2217\/pgs-2022-0135","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,18]],"date-time":"2024-05-18T02:40:52Z","timestamp":1716000052000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.2217\/pgs-2022-0135"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1]]},"references-count":79,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2023,1]]}},"alternative-id":["10.2217\/pgs-2022-0135"],"URL":"https:\/\/doi.org\/10.2217\/pgs-2022-0135","relation":{},"ISSN":["1462-2416","1744-8042"],"issn-type":[{"value":"1462-2416","type":"print"},{"value":"1744-8042","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,1]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ipgs20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ipgs20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2022-09-18","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-12-06","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-01-13","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}